Theravance Biopharma, Inc. - TBPH
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Newtyn Management, LLC | 6.7% | 3,434,191 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Newtyn TE Partners, LP | 4.3% | 2,212,712 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Madison Avenue International LP | 17.7% | 9,212,252 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Madison Avenue Partners, LP | 17.7% | 9,212,252 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | EMAI Management, LLC | 17.7% | 9,212,252 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Madison Avenue GP, LLC | 17.7% | 9,212,252 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Caraway Jackson Investments LLC | 17.7% | 9,212,252 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Eli Samaha | 17.7% | 9,212,252 | View |
| Mar 25, 2026 | SCHEDULE 13D/A | — | 9.0% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.